21.01.2026
Artificial intelligence in medicine: the turning point is here.
Five years ago, AI in medicine sounded like a promise. Today, it’s becoming an industry.
Google has just crossed a decisive threshold, Isomorphic Labs is preparing clinical trials, and AI-designed drugs could shrink a 15-year process to a matter of months. This is no longer about algorithms supporting research – it’s about redefining how medicine is discovered, tested, and delivered.
Behind the technology lies a massive economic shift: healthcare, data, code, and capital are converging. For patients, it means faster treatments. For pharma, a new operating model. For investors, a frontier that is just opening.
Watch the video by John Plassard, Partner & Head of Investment Strategy at Cité Gestion!
More articles
09.02.2026
Forum Horizon 2026 – event highlights
Faced with global economic turmoil, what course should Switzerland pursue?
A look back at the Forum Horizon 2026, held on 29 January 2026 at IMD Lausanne.
03.02.2026
Kevin Warsh at the Fed: A Power Grab or a Credibility Reset?
Kevin Warsh’s nomination as the next Chair of the Federal Reserve has triggered sharp market reactions — but also widespread misunderstandings.
Read more26.01.2026
Welcome to Norma Hedinger!
We are pleased to share the arrival of Norma Hedinger as a banker at Cité Gestion.
Read more13.01.2026
Welcome to Raffael Iberg!
We are pleased to share the arrival of Raffael Iberg as an Investment Advisor at Cité Gestion.
Read more07.01.2026
Outlook 2026 – After the year of the 3D, welcome to the 3R Scenario!
After two exceptional years for markets, 2026 is not about euphoria - it’s about the 3R: Repricing, Rotation, and Resilience.
Read more30.12.2025
On behalf of the entire Cité Gestion team : Happy New Year 2026 !
As 2025 has been an intense year for the financial world, we would like to thank you for staying engaged with us.
Read more
